<--- Back to Details
First PageDocument Content
Immune system / Pharmacology / Emerging technologies / Monoclonal antibodies / Biopharmaceutical / Artificial cell / Immunogenicity / Antibody / Oligonucleotide / Biology / Biotechnology / Immunology
Date: 2007-10-05 23:42:22
Immune system
Pharmacology
Emerging technologies
Monoclonal antibodies
Biopharmaceutical
Artificial cell
Immunogenicity
Antibody
Oligonucleotide
Biology
Biotechnology
Immunology

Add to Reading List

Source URL: media.wiley.com

Download Document from Source Website

File Size: 93,61 KB

Share Document on Facebook

Similar Documents

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v8Wa - View Document

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

DocID: 1v7ko - View Document

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v72B - View Document

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

DocID: 1v5W2 - View Document

TERMINOLOGY What is a Biopharmaceutical?

DocID: 1v5mX - View Document